Three anti-coronavirus drugs prescribed in Japan, including molnupiravir, may be effective against the omicron subvariant BA.5, according to a study published in the New England Journal of Medicine on Thursday.
A team led by Yoshihiro Kawaoka, a professor of virology at the University of Tokyo, found that small-molecule antiviral drugs nirmatrelvir, molnupiravir and remdesivir curbed virus activity in cultured monkey cells infected with the highly contagious BA.5 and other strains.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
PHOTO GALLERY (CLICK TO ENLARGE)
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.